Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/149576
Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
There is a subtype of breast cancer characterized by the overexpression of the oncogene HER2. Although most patients with this diagnosis benefit from HER2-targeted treatments, some do not respond to these therapies and others develop resistance with time. New tools are therefore warranted for the treatment of this patient population, and for early identification of those individuals at a higher risk of developing innate or acquired resistance to current treatments. Here, we show that HER2 forms heteromer complexes with the cannabinoid receptor CB2R, the expression of these structures correlates with poor patient prognosis, and their disruption promotes antitumor responses. Collectively, our results support HER2-CB2R heteromers as new therapeutic targets and prognostic tools in HER2+ breast cancer
Matèries
Matèries (anglès)
Citació
Citació
BLASCO-BENITO, Sandra, MORENO GUILLÉN, Estefanía, SEIJO-VILA, Marta, TUNDIDOR, Isabel, ANDRADAS, Clara, CAFFAREL, María m., CARO-VILLALOBOS, Miriam, URIGÜEN, Leyre, DIEZ-ALARCIA, Rebeca, MORENO-BUENO, Gema, HERNÁNDEZ, Lucía, MANSO, Luis, HOMAR RUANO, Patricia c., MCCORMICK, Peter j., BIBIC, Lucka, BERNADÓ MORALES, Cristina, ARRIBAS, Joaquín v. (vicente), CANALS BUJ, Meritxell, CASADÓ, Vicent, CANELA CAMPOS, Enric i. (enric isidre), GUZMÁN, Manuel, PÉREZ-GÓMEZ, Eduardo, SÁNCHEZ MORA, Cristina. Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer. _Proceedings of the National Academy of Sciences of the United States of America - PNAS_. 2019. Vol. 116, núm. 9, pàgs. 3863-3872. [consulta: 27 de gener de 2026]. ISSN: 0027-8424. [Disponible a: https://hdl.handle.net/2445/149576]